Drug discovery

14 August 2025
Biochemical assays for kinase activity in drug discovery

Optimizing Biochemical Assays for Kinase Activity in Drug Discovery

How biochemical assays enhance kinase activity detection in drug discovery. Assay formats, fluorescent ligands, and pathway insights for R&D success.
24 July 2025
Biochemical Assays in Drug Discovery

Biochemical Assays in Drug Discovery: From Target Validation to Therapeutic Development

Biochemical assays drive drug discovery from target validation to therapeutic development. Discover assay formats, examples, and key optimization strategies.
27 March 2025
Fluorescent Ligands in Fluorescence Polarization Assays

Fluorescent Ligands in Fluorescence Polarization Assays: A Game-Changer for GPCR Drug Discovery

The development of new therapeutics depends on the ability to identify compounds that interact with specific molecular targets involved in disease pathways. Target-based screening has become […]
11 September 2023

Celtarys and G.CLIPS join forces to revolutionize transmembrane proteins characterization in drug discovery. 

A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions […]
7 July 2023

Discover Our New Fluorescent Ligands For AT1

Our portfolio of #GPCR#fluorescent ligands is growing.We have just added to our catalogue more fluorescent ligands for the AT1 receptor, CELT-145 and CELT-252. The Angiotensin AT1 receptor belongs to the […]
7 March 2023

Game Changer in Target-Based Drug Discovery  

A different way to monitor GPCR binding, target engagement and internalization with a new fluorescent-conjugate toolbox.     The past decade has witnessed fluorescently tagged drug molecules gaining […]